Skip to main content

Celcuity Inc.

CELC
Exchange
Nasdaq
Industry
Services-Medical Laboratories
SEC CIK
0001603454

In the last 90 days, Celcuity Inc. insiders filed 0 open-market purchases and 1 sale; 273 institutions reported holding it in 13F filings for Q2 2026, worth $5.95B in total; no superinvestor holds it.

Q2 2022 vs. Q1 2022

How the institutions holding Celcuity Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of CELC: Q1 2022 compared with Q2 2022
MeasureQ1 2022Of which not filed for Q2 2022Q2 2022Change
Holders53241−10
Shares5.28M14.8K4.67M−587.7K (−11.2%)
Value$47.9M$139.0K$42.5M−$5.24M (−11.0%)

2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (7)

Institutions that held Celcuity Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to CELC in Q2 2022
InstitutionSharesValue% of portfolio
Ergoteles LLC46,954$427.0K0.01%
Citadel Advisors LLC28,115$256.0K0.00%
Corton Capital Inc.22,560$205.0K0.19%
Delphia (USA) Inc.21,312$194.0K0.13%
Cresset Asset Management, LLC13,223$120.0K0.00%
FMR LLC126$1.00K0.00%
Credit Suisse AG5$00.00%

Sold out (17)

Institutions that held Celcuity Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Not filed for Q2 2022 yet (2)

Institutions that held Celcuity Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CELC in Q1 2022 that haven't filed for Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Meristem Family Wealth, LLC13,223$124.0K
Amalgamated Financial Corp.1,574$15.0K